A good practice guide for prescription cannabis clinics has been published by the Cannabis Industry Council (CIC). The guidance includes 10 principles of good practice, as well as five specific policies for clinics to implement. The aim of the good practice guide is to encourage ethical and responsible operations, build industry collaboration, and deliver improved […]
Read More
The “number of items for private prescribing of unlicensed cannabis-based medicines” increased from 6,137 in September 2021 to 22,431 in September 2023. That’s according to an NHS Business Services Authority response to a freedom of information request. Business of Cannabis report that this equates to an compound annual growth rate of 83%. However, the UK […]
Read More
The Cannabis Industry Council (CIC) is pleased to announce three new additions to our Executive Committee, as follows: Standards Working Group Chair – Frances Crewdson (CannDo Consulting) Prescription Working Group Co-Chair – Sonal Patel (Aurora) Supply Chain Representative – James Leavesley (Dalgety) A very warm welcome to Frances, Sonal and James. We look forward to […]
Read More
The CIC has written to the Advisory Council on the Misuse of Drugs (ACMD) calling on them to back raising the THC permissable in hemp crops. The Government previously asked the ACMD to advise them on potentially increasing the limit to “at least 0.3%”. The CIC has also urged the ACMD to support a reduction […]
Read More
Landlords, property managers, and housing associations are currently at risk of breaching the Equality Act over their approach to prescription cannabis, according to a new Cannabis Industry Council (CIC) report. Entitled ‘The Use of Prescription Cannabis in Buildings’, the report reminds housing providers of their obligations under the Equality Act 2010, which prohibits discrimination based […]
Read More
Voting is open for the inaugural Cannabis Industry Awards, with two individual awards set to be handed out later this year. The two individual outstanding achievement awards are for Social Impact and Contribution to Science. The shortlist is as follows: Contribution to Science Award (sponsored by Gowling WLG) Alkyoni Athanasiou-Fragkouli and Prof. Michael Lynskey (Drug […]
Read More
The CIC and Drug Science have written to new Drugs Minister Dame Diana Johnson MP, calling for a liberalisation of the regulations around research. We are calling on the Government to back a number of recommendations they have received from the Advisory Council on the Misuse of Drugs (ACMD). Implementing these recommendations will reduce licencing […]
Read More
The CIC is pleased to welcome Luke Strong as our newest Student Ambassador. Luke is currently a second-year philosophy student at Queen’s University Belfast. He eagerly wants to aid in the pursuit of ethically realising the medicinal potential of cannabis and psychedelics. Luke aspires to contribute to these industries from a policy perspective, advocating for […]
Read More
The Care Quality Commission (CQC) has recently released a report called ‘The safer management of controlled drugs: annual update 2023‘. In a section entitled ‘Administration of CBPMs in health and social care settings’, the CQC have advised that providers (e.g. clinics, pharmacies) should consider the following in their policies and processes: ensuring the product has […]
Read More
A new report from the Care Quality Commission has found an increase in CBPM prescriptions of 118 per cent from 2021/22 to 2022/23. Specifically, the numbers released were as follows: 1 July 2021 to 30 June 2022: 81,476 items dispensed. 1 July 2022 to 30 June 2023: 177,566 items dispensed. This data relates specifically to […]
Read More